Work

Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2 ‑associated sensitivity in ACHN models

Year: 2025
Type: article
Abstract: -enriched papillary RCC for biomarker‑guided repurposing and motivating protein‑level and genetic validation.
Institution: Yonsei University
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W4416854439
FWCI:
Cites:
Cited by:
Related to: